Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Tau immunoreactivity in peripheral tissues of human aging and select tauopathies.

Dugger BN, Hoffman BR, Scroggins A, Serrano GE, Adler CH, Shill HA, Belden CM, Sabbagh MN, Caviness JN, Driver Dunckley E, Beach TG.

Neurosci Lett. 2018 Dec 21;696:132-139. doi: 10.1016/j.neulet.2018.12.031. [Epub ahead of print]

PMID:
30579993
2.

Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?

Gupta HV, Mehta SH, Zhang N, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Belden CM, Dugger BN, Beach TG, Serrano GE, Sue LI, Davis K, Adler CH.

Mov Disord Clin Pract. 2018 Feb 22;5(2):165-170. doi: 10.1002/mdc3.12589. eCollection 2018 Mar-Apr.

PMID:
30363433
3.

Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study.

Savica R, Beach TG, Hentz JG, Sabbagh MN, Serrano GE, Sue LI, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Mehta SH, Jacobson SA, Belden CM, Davis KJ, Zamrini E, Shprecher DR, Adler CH.

Acta Neurol Scand. 2019 Jan;139(1):76-81. doi: 10.1111/ane.13028. Epub 2018 Oct 7.

PMID:
30229861
4.

Essential tremor and depression.

Aslam S, Zhang N, Adler CH, Caviness JN, Driver-Dunckley E, Mehta SH, Sabbagh MN, Belden C, Zamrini E, Beach TG, Shill HA.

Mov Disord Clin Pract. 2017 Nov-Dec;4(6):838-842. doi: 10.1002/mdc3.12530. Epub 2017 Jul 17.

5.

Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosis.

Shprecher DR, Adler CH, Zhang N, Hentz JG, Serrano GE, Dugger BN, Shill HA, Savica R, Caviness JN, Sabbagh MN, Belden CM, Driver-Dunckley E, Mehta SH, Sue LI, Davis KJ, Zamrini E, Beach TG.

Parkinsonism Relat Disord. 2018 Oct;55:92-96. doi: 10.1016/j.parkreldis.2018.05.020. Epub 2018 May 17.

PMID:
29779682
6.

Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.

Chen T, Mirzadeh Z, Chapple KM, Lambert M, Shill HA, Moguel-Cobos G, Tröster AI, Dhall R, Ponce FA.

J Neurosurg. 2018 Mar 1:1-12. doi: 10.3171/2017.8.JNS17883. [Epub ahead of print]

PMID:
29547091
7.

Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.

Pal G, Ouyang B, Verhagen L, Serrano G, Shill HA, Adler CH, Beach TG, Kordower JH; AZSAND.

Mov Disord. 2018 Apr;33(4):652-654. doi: 10.1002/mds.27280. Epub 2018 Jan 30. No abstract available.

PMID:
29380902
8.

Association Between Pathology and Electroencephalographic Activity in Parkinson's Disease.

Caviness JN, Beach TG, Hentz JG, Shill HA, Driver-Dunckley ED, Adler CH.

Clin EEG Neurosci. 2018 Sep;49(5):321-327. doi: 10.1177/1550059417696179. Epub 2017 Feb 1.

PMID:
29161906
9.

Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype.

Gerkin RC, Adler CH, Hentz JG, Shill HA, Driver-Dunckley E, Mehta SH, Sabbagh MN, Caviness JN, Dugger BN, Serrano G, Belden C, Smith BH, Sue L, Davis KJ, Zamrini E, Beach TG.

Ann Clin Transl Neurol. 2017 Sep 8;4(10):714-721. doi: 10.1002/acn3.447. eCollection 2017 Oct.

10.

GBA mutations in Parkinson disease: earlier death but similar neuropathological features.

Adler CH, Beach TG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Patel A, Sue LI, Serrano G, Jacobson SA, Davis K, Belden CM, Dugger BN, Paciga SA, Winslow AR, Hirst WD, Hentz JG.

Eur J Neurol. 2017 Nov;24(11):1363-1368. doi: 10.1111/ene.13395. Epub 2017 Aug 17.

11.

Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.

Pal GD, Ouyang B, Serrano G, Shill HA, Goetz C, Stebbins G, Metman LV, Driver-Dunckley E, Mehta SH, Caviness JN, Sabbagh MN, Adler CH, Beach TG; Arizona Study of Aging Neurodegenerative Disorders.

Mov Disord. 2017 Feb;32(2):274-277. doi: 10.1002/mds.26882. Epub 2016 Dec 2.

PMID:
27911008
12.

Knowledge gaps and research recommendations for essential tremor.

Hopfner F, Haubenberger D, Galpern WR, Gwinn K, Van't Veer A, White S, Bhatia K, Adler CH, Eidelberg D, Ondo W, Stebbins GT, Tanner CM, Helmich RC, Lenz FA, Sillitoe RV, Vaillancourt D, Vitek JL, Louis ED, Shill HA, Frosch MP, Foroud T, Kuhlenbäumer G, Singleton A, Testa CM, Hallett M, Elble R, Deuschl G.

Parkinsonism Relat Disord. 2016 Dec;33:27-35. doi: 10.1016/j.parkreldis.2016.10.002. Epub 2016 Oct 4. Review.

13.

Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303).

Isaacson S, Shill HA, Vernino S, Ziemann A, Rowse GJ.

J Parkinsons Dis. 2016 Oct 19;6(4):751-759. doi: 10.3233/JPD-160860.

PMID:
27636856
14.

Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.

Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE.

J Neuropathol Exp Neurol. 2016 Jun 12. pii: nlw047. [Epub ahead of print]

PMID:
27297671
15.

Graph theory network function in Parkinson's disease assessed with electroencephalography.

Utianski RL, Caviness JN, van Straaten EC, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH, Hentz JG.

Clin Neurophysiol. 2016 May;127(5):2228-36. doi: 10.1016/j.clinph.2016.02.017. Epub 2016 Mar 4.

PMID:
27072094
16.

Cortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's disease.

Caviness JN, Lue LF, Hentz JG, Schmitz CT, Adler CH, Shill HA, Sabbagh MN, Beach TG, Walker DG.

Mov Disord. 2016 Jul;31(7):1012-9. doi: 10.1002/mds.26621. Epub 2016 Apr 8.

17.

Lewy bodies are incidental in essential tremor.

Shill HA, Adler CH, Beach TG.

Parkinsonism Relat Disord. 2016 May;26:81. doi: 10.1016/j.parkreldis.2016.02.025. Epub 2016 Mar 3. No abstract available.

PMID:
27010072
18.

Converging mediators from immune and trophic pathways to identify Parkinson disease dementia.

Lue LF, Schmitz CT, Snyder NL, Chen K, Walker DG, Davis KJ, Belden C, Caviness JN, Driver-Dunckley E, Adler CH, Sabbagh MN, Shill HA.

Neurol Neuroimmunol Neuroinflamm. 2016 Jan 27;3(1):e193. doi: 10.1212/NXI.0000000000000193. eCollection 2016 Feb.

19.

Simplified conversion method for unified Parkinson's disease rating scale motor examinations.

Hentz JG, Mehta SH, Shill HA, Driver-Dunckley E, Beach TG, Adler CH.

Mov Disord. 2015 Dec;30(14):1967-70. doi: 10.1002/mds.26435. Epub 2015 Nov 17.

20.

Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Beach TG, Adler CH, Serrano G, Sue LI, Walker DG, Dugger BN, Shill HA, Driver-Dunckley E, Caviness JN, Intorcia A, Filon J, Scott S, Garcia A, Hoffman B, Belden CM, Davis KJ, Sabbagh MN; Arizona Parkinson's Disease Consortium.

J Parkinsons Dis. 2016;6(1):153-63. doi: 10.3233/JPD-150680.

21.

Lewy bodies in essential tremor are no different than in controls.

Shill HA, Adler CH, Beach TG.

Parkinsonism Relat Disord. 2016 Feb;23:106-7. doi: 10.1016/j.parkreldis.2015.11.025. Epub 2015 Nov 24. No abstract available.

22.

Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts.

Caviness JN, Utianski RL, Hentz JG, Beach TG, Dugger BN, Shill HA, Driver-Dunckley ED, Sabbagh MN, Mehta S, Adler CH.

Eur J Neurol. 2016 Feb;23(2):387-92. doi: 10.1111/ene.12878. Epub 2015 Oct 31.

PMID:
26518336
23.

Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.

Dugger BN, Davis K, Malek-Ahmadi M, Hentz JG, Sandhu S, Beach TG, Adler CH, Caselli RJ, Johnson TA, Serrano GE, Shill HA, Belden C, Driver-Dunckley E, Caviness JN, Sue LI, Jacobson S, Powell J, Sabbagh MN.

BMC Neurol. 2015 Aug 20;15:146. doi: 10.1186/s12883-015-0403-4.

24.

REM sleep behavior disorder and neuropathology in Parkinson's disease.

Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG.

Mov Disord. 2015 Sep;30(10):1413-7. doi: 10.1002/mds.26347. Epub 2015 Aug 12.

PMID:
26265105
25.

Unawareness of Hyposmia in Elderly People With and Without Parkinson's Disease.

Shill HA, Hentz JG, Caviness JN, Driver-Dunckley E, Jacobson S, Belden C, Sabbagh MN, Beach TG, Adler CH.

Mov Disord Clin Pract. 2015 Jul 17;3(1):43-47. doi: 10.1002/mdc3.12220. eCollection 2016 Jan-Feb.

26.

Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients.

Mu L, Chen J, Sobotka S, Nyirenda T, Benson B, Gupta F, Sanders I, Adler CH, Caviness JN, Shill HA, Sabbagh M, Samanta JE, Sue LI, Beach TG; Arizona Parkinson's Disease Consortium.

Dysphagia. 2015 Aug;30(4):404-17. doi: 10.1007/s00455-015-9612-7. Epub 2015 Jun 4.

27.

Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG, Lue L, Roher AE, Dugger BN, Maarouf C, Birdsill AC, Intorcia A, Saxon-Labelle M, Pullen J, Scroggins A, Filon J, Scott S, Hoffman B, Garcia A, Caviness JN, Hentz JG, Driver-Dunckley E, Jacobson SA, Davis KJ, Belden CM, Long KE, Malek-Ahmadi M, Powell JJ, Gale LD, Nicholson LR, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Burke AD, Reiman EM, Sabbagh MN.

Neuropathology. 2015 Aug;35(4):354-89. doi: 10.1111/neup.12189. Epub 2015 Jan 26.

28.

Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson's disease.

Caviness JN, Hentz JG, Belden CM, Shill HA, Driver-Dunckley ED, Sabbagh MN, Powell JJ, Adler CH.

J Parkinsons Dis. 2015;5(1):117-24. doi: 10.3233/JPD-140480.

PMID:
25420672
29.

Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy Pathology.

Rigby HB, Dugger BN, Hentz JG, Adler CH, Beach TG, Shill HA, Driver-Dunckley E, Sabbagh MN, Sue LI, Caviness JN.

Mov Disord Clin Pract. 2014 Oct 29;2(1):33-38. doi: 10.1002/mdc3.12104. eCollection 2015 Mar.

30.

Olfactory dysfunction in incidental Lewy body disease and Parkinson's disease.

Driver-Dunckley E, Adler CH, Hentz JG, Dugger BN, Shill HA, Caviness JN, Sabbagh MN, Beach TG; Arizona Parkinson Disease Consortium.

Parkinsonism Relat Disord. 2014 Nov;20(11):1260-2. doi: 10.1016/j.parkreldis.2014.08.006. Epub 2014 Aug 16.

31.

Reply: Purkinje cell loss in essential tremor.

Shill HA, Adler CH, Hentz JG.

Mov Disord. 2014 Sep;29(10):1330-1. doi: 10.1002/mds.25954. Epub 2014 Aug 1. No abstract available.

PMID:
25087570
32.

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.

Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JN, Hu C; Arizona Parkinson's Disease Consortium.

Parkinsonism Relat Disord. 2014 Sep;20(9):1009-14. doi: 10.1016/j.parkreldis.2014.06.018. Epub 2014 Jun 28.

33.

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.

Adler CH, Beach TG, Hentz JG, Shill HA, Caviness JN, Driver-Dunckley E, Sabbagh MN, Sue LI, Jacobson SA, Belden CM, Dugger BN.

Neurology. 2014 Jul 29;83(5):406-12. doi: 10.1212/WNL.0000000000000641. Epub 2014 Jun 27.

34.

Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects.

Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N; Arizona Parkinson's Disease Consortium.

Neurosci Lett. 2014 Jun 13;571:34-8. doi: 10.1016/j.neulet.2014.04.027. Epub 2014 Apr 28.

35.

PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders.

Siderowf A, Pontecorvo MJ, Shill HA, Mintun MA, Arora A, Joshi AD, Lu M, Adler CH, Galasko D, Liebsack C, Skovronsky DM, Sabbagh MN.

BMC Neurol. 2014 Apr 9;14:79. doi: 10.1186/1471-2377-14-79.

36.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
37.

Concomitant pathologies among a spectrum of parkinsonian disorders.

Dugger BN, Adler CH, Shill HA, Caviness J, Jacobson S, Driver-Dunckley E, Beach TG; Arizona Parkinson's Disease Consortium.

Parkinsonism Relat Disord. 2014 May;20(5):525-9. doi: 10.1016/j.parkreldis.2014.02.012. Epub 2014 Feb 22.

38.

Essential tremor is not associated with cerebellar Purkinje cell loss.

Symanski C, Shill HA, Dugger B, Hentz JG, Adler CH, Jacobson SA, Driver-Dunckley E, Beach TG.

Mov Disord. 2014 Apr;29(4):496-500. doi: 10.1002/mds.25845. Epub 2014 Feb 15.

PMID:
24532134
39.

Submandibular gland needle biopsy for the diagnosis of Parkinson disease.

Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, Henry-Watson J, Serrano G, Sue LI, Nagel T, Duffy A, Shill HA, Akiyama H, Walker DG, Beach TG.

Neurology. 2014 Mar 11;82(10):858-64. doi: 10.1212/WNL.0000000000000204. Epub 2014 Feb 5.

40.

Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers.

Dugger BN, Hentz JG, Adler CH, Sabbagh MN, Shill HA, Jacobson S, Caviness JN, Belden C, Driver-Dunckley E, Davis KJ, Sue LI, Beach TG.

J Neuropathol Exp Neurol. 2014 Mar;73(3):244-52. doi: 10.1097/NEN.0000000000000046. Erratum in: J Neuropathol Exp Neurol. 2014 Jul;73(7):732.

41.

Essential Tremor in the Elderly and Risk for Dementia.

Shill HA, Hentz JG, Jacobson SA, Belden C, Sabbagh MN, Beach TG, Driver-Dunckley E, Adler CH.

J Neurodegener Dis. 2014;2014:328765. doi: 10.1155/2014/328765. Epub 2014 Apr 9.

42.

SMG1 identified as a regulator of Parkinson's disease-associated alpha-synuclein through siRNA screening.

Henderson-Smith A, Chow D, Meechoovet B, Aziz M, Jacobson SA, Shill HA, Sabbagh MN, Caviness JN, Adler CH, Driver-Dunckley ED, Beach TG, Yin H, Dunckley T.

PLoS One. 2013 Oct 30;8(10):e77711. doi: 10.1371/journal.pone.0077711. eCollection 2013.

43.

Causes of imbalance and abnormal gait that may be misdiagnosed.

Shill HA, Fife TD.

Semin Neurol. 2013 Jul;33(3):270-5. doi: 10.1055/s-0033-1354601. Epub 2013 Sep 21. Review.

PMID:
24057830
44.

Parkinson disease affects peripheral sensory nerves in the pharynx.

Mu L, Sobotka S, Chen J, Su H, Sanders I, Nyirenda T, Adler CH, Shill HA, Caviness JN, Samanta JE, Sue LI, Beach TG; Arizona Parkinson’s Disease Consortium.

J Neuropathol Exp Neurol. 2013 Jul;72(7):614-23. doi: 10.1097/NEN.0b013e3182965886.

45.

Quantitative appraisal of ventricular cerebrospinal fluid biomarkers in neuropathologically diagnosed Parkinson's disease cases lacking Alzheimer's disease pathology.

Maarouf CL, Beach TG, Adler CH, Malek-Ahmadi M, Kokjohn TA, Dugger BN, Walker DG, Shill HA, Jacobson SA, Sabbagh MN, Roher AE; Arizona Parkinson’s Disease Consortium.

Biomark Insights. 2013;8:19-28. doi: 10.4137/BMI.S11422. Epub 2013 Mar 12.

46.

Submandibular gland biopsy for the diagnosis of Parkinson disease.

Beach TG, Adler CH, Dugger BN, Serrano G, Hidalgo J, Henry-Watson J, Shill HA, Sue LI, Sabbagh MN, Akiyama H; Arizona Parkinson’s Disease Consortium.

J Neuropathol Exp Neurol. 2013 Feb;72(2):130-6. doi: 10.1097/NEN.0b013e3182805c72.

47.

Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease.

Mu L, Sobotka S, Chen J, Su H, Sanders I, Adler CH, Shill HA, Caviness JN, Samanta JE, Beach TG; Arizona Parkinson’s Disease Consortium.

J Neuropathol Exp Neurol. 2013 Feb;72(2):119-29. doi: 10.1097/NEN.0b013e3182801cde.

48.

Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized Cohort.

Malek-Ahmadi M, Kahlon V, Adler CH, Obradov A, Thind K, Shill HA, Sue LI, Caviness JN, Jacobson S, Sabbagh MN.

Clin Exp Med Sci. 2013;1(7):317-327.

49.

Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

Walker DG, Lue LF, Adler CH, Shill HA, Caviness JN, Sabbagh MN, Akiyama H, Serrano GE, Sue LI, Beach TG; Arizona Parkinson Disease Consortium.

Exp Neurol. 2013 Feb;240:190-204. doi: 10.1016/j.expneurol.2012.11.020. Epub 2012 Nov 28.

50.

Essential tremor is not a neurodegenerative disease.

Rajput AH, Adler CH, Shill HA, Rajput A.

Neurodegener Dis Manag. 2012 Jun;2(3):259-268.

Supplemental Content

Loading ...
Support Center